In association with
Why you should attend:
Analyse development priorities
Discuss synergy strategies – what can be improved & what works well?
Hear ideas on how to improve COPD drug development
Explore how big Pharma can gain from co-operation with smaller pharmaceuticals companies
Join an interactive discussion session
Network with key industry professionals
Who should attend this event?
Industry professionals in positions such as:
- Associate Clinician
- Associate Director
- Biomarker Specialist
- Brand Manager
- Business Development Director
- CEO
- Chief Executive Officer
- Chief Medical Officer
- Chief Scientific Officer
- Clinical & Regulatory Strategy Manager
- Clinical Pharmacologist
- Clinical Trial Manager
- Commercial Director
- CSO
- Director
- Director of Medical Affairs
|
- Head Global Licensing Respiratory
- Head of Clinical Science
- Head of Discovery
- Head of Global Data Informatics - Global Preclinical R&D
- Head of In-Vitro Biology
- Head of Pharmacology
- Head of Respiratory Pharmacology
- Managing Director
- Medical Affairs Director
- Medical Director
- Principal Scientist
- Vice President
- VP Chemistry
- VP Inflammatory Disease Area
- VP, Clinical Research Immunology
- VP, Research
|
|
What is this event about?
Asthma & COPD drug development of novel anti-inflammatory drugs is a problem for both big & small pharma companies. There are no predictive biomarkers for long term clinical benefit, limited knowledge on complex disease pathology and regulatory endpoints often do not reflect drug action. Challenges for small companies include the need for long clinical studies to demonstrate clinical benefit. Should small Pharma concentrate on early development including clinical Proof of Concept and what does this constitute for asthma and COPD? What kind of data package, including non-clinical safety, is expected by big Pharma for licensing etc ("selling package"). What are the key differences between clinically validated and non-validated targets? Expectations & needs of big Pharma differ: entry at what stage, portfolio aspects (e.g. combination therapy), devices ("should fit in existing device"). There is a clear need for early communication in order to learn about expectations. How can this process be synergized, all the way through from early joint development to trade selling?
This workshop will address these issues in an informal and progressive manner. Participants are encouraged to maximise the interactive nature of the workshop through participation and discussion.
Who is leading this event?
Daniel Bock, Chief Scientific Officer, Revotar
Workshop agenda
Introduction by workshop leaders (scope of the workshop) Drug development of anti-inflammatory drugs in Asthma & COPD: challenges for small pharmaceutical companies Asthma & COPD drug development in big pharma: how to profit from small companies (options & expectations) How to synergize drug development of small and big pharma: general considerations, need for improvement, successful examples
VENUE
Copthorne Tara Hotel
Scarsdale Place, Kensington, London, United Kingdom
The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.
The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.
A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
HOTEL BOOKING FORM
copyright ©
2024
SAE Media Group
|